Based on the LifeMD Inc stock forecast from 6 analysts, the average analyst target price for LifeMD Inc is USD 11.30 over the next 12 months. LifeMD Inc’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of LifeMD Inc is Slightly Bearish, which is based on 3 positive signals and 6 negative signals. At the last closing, LifeMD Inc’s stock price was USD 5.77. LifeMD Inc’s stock price has changed by +15.63% over the past week, -15.89% over the past month and -31.15% over the last year.
No recent analyst target price found for LifeMD Inc
No recent average analyst rating found for LifeMD Inc
Company Overview LifeMD Inc
LifeMD, Inc. operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for medical care in the United States. The company offers telehealth platform comprising RexMD, a men's telehealth brand that provides access to virtual medical treatment for a variety of men's health needs from licensed physician; ShapiroMD that provides virtual medical treatment, prescription medications, patented doctor formulated OTC products, topical compounded medications, and medical devices treating male and female hair loss; NavaMD, a female-oriented tele-dermatology that offers virtual medical treatment from dermatologists and other providers; and prescription oral and compounded topical medications to treat aging and acne; and Cleared which provides personalized treatments for allergy, asthma and immunology, including in-home tests for both environmental and food allergies, prescriptions for allergies and asthma and immunotherapies for treating chronic allergies. It also provides LifeMD PC, a direct-to-consumer virtual primary care which includes 24/7 access to a provider for their primary care, urgent care, and chronic care needs; and offers virtual consultations and treatment, prescription medications, diagnostics and imaging, wellness coaching, and more. In addition, the company offers PDFSimpli, an online software as a service platform that allows users to create, edit, convert, sign, and share PDF documents; ResumeBuild which provides digital resume and cover letter services; SignSimpli, a digital signature platform; and LegalSimpli, a provider of legal forms for consumers and small businesses. It sells its products directly to consumers and through e-commerce platforms, as well as through third party partner channels. The company was formerly known as Conversion Labs, Inc. and changed its name to LifeMD, Inc. in February 2021. LifeMD, Inc. was incorporated in 1994 and is headquartered in New York, New York. Read Less
LifeMD, Inc. operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for medical care in the United States. The company offers telehealth platform comprising RexMD, a men's telehealth brand that provides access to virtual medical tre...Read More
Frequently Asked Questions About LifeMD Inc (LFMD) Stock
Based on ratings from 6 analysts LifeMD Inc's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Slightly Bearish. The stock has 8 buy, sell and 2 hold ratings.
Unfortunately we do not have enough data on LFMD's stock to indicate if its a good dividend stock.
Based on targets from 6 analysts, the average taret price for LFMD is USD 11.30 over the next 12 months. The maximum analyst target price is USD 15 while the minimum anlayst target price is USD 7.
Unfortunately we do not have enough data on LFMD's stock to indicate if its overvalued.
The last closing price of LFMD's stock was USD 5.77.
The most recent market capitalization for LFMD is USD 0.24B.
Based on targets from 6 analysts, the average taret price for LFMD is projected at USD 11.30 over the next 12 months.
This means that LFMD's stock price may go up by +95.84% over the next 12 months.
We can't find any ETFs which contains LifeMD Inc's stock.
As per our most recent records LifeMD Inc has 207 Employees.
LifeMD Inc's registered address is 236 Fifth Avenue, New York, NY, United States, 10001.
You can get more information about it from LifeMD Inc's website at https://lifemd.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Superior risk adjusted returns
This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.
Positive cash flow
The company had positive total cash flow in the most recent four quarters.
Superior Revenue Growth
This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.
What not to like
Overpriced compared to book value
The stock is trading high compared to its peers median on a price to book value basis.
High volatility
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
Low market capitalization
This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.
Overpriced on cashflow basis
The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Negative free cash flow
The company had negative total free cash flow in the most recent four quarters.
Low Earnings Growth
This stock has shown below median earnings growth in the previous 5 years compared to its sector
Frequently Asked Questions About LifeMD Inc (LFMD) Stock
Based on ratings from 6 analysts LifeMD Inc's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Slightly Bearish. The stock has 8 buy, sell and 2 hold ratings.
Unfortunately we do not have enough data on LFMD's stock to indicate if its a good dividend stock.
Based on targets from 6 analysts, the average taret price for LFMD is USD 11.30 over the next 12 months. The maximum analyst target price is USD 15 while the minimum anlayst target price is USD 7.
Unfortunately we do not have enough data on LFMD's stock to indicate if its overvalued.
The last closing price of LFMD's stock was USD 5.77.
The most recent market capitalization for LFMD is USD 0.24B.
Based on targets from 6 analysts, the average taret price for LFMD is projected at USD 11.30 over the next 12 months.
This means that LFMD's stock price may go up by +95.84% over the next 12 months.
We can't find any ETFs which contains LifeMD Inc's stock.
As per our most recent records LifeMD Inc has 207 Employees.
LifeMD Inc's registered address is 236 Fifth Avenue, New York, NY, United States, 10001.
You can get more information about it from LifeMD Inc's website at https://lifemd.com.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for LFMD !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
